1H核磁共振波谱揭示慢性静脉疾病患者代谢表型与疾病分期相关变化
这项前瞻性病例对照研究纳入622名参与者(517例有症状CVD患者和105名无症状志愿者),采用1H-NMR检测血尿代谢物,发现血清芳香族氨基酸与CEAP临床分级升高正相关,尿甲酸、肌酐、甘氨酸、柠檬酸、琥珀酸、丙酮酸和2-羟基异丁酸与CEAP临床分级升高负相关,均p<.001。
要点
- 血清芳香族氨基酸与CEAP临床分级升高正相关(p<.001)。
- 尿甲酸、肌酐、甘氨酸、柠檬酸、琥珀酸、丙酮酸和2-羟基异丁酸与CEAP临床分级升高负相关(p<.001)。
- 上述代谢物涉及三羧酸循环、缺氧诱导因子通路及一碳代谢。
核心结论
- 1H-NMR非靶向生物体液分析检测到与CVD存在及严重程度相关的代谢物,提示相关生物学通路,并为未来研究提供候选生物标志物。
研究设计与样本
- 前瞻性病例对照研究,连续纳入单中心有症状CVD患者和无症状志愿者,进行临床评估、静脉双功超声及血尿采样,按CEAP分类定义疾病分期,行1H-NMR实验并用多变量统计技术分析数据。
主要发现
- 共纳入622名参与者,包括517例有症状CVD患者(毛细血管扩张[C1] 0.6%、静脉曲张[C2] 48.5%、肿胀[C3] 12.0%、皮肤改变[C4] 27.7%、愈合或活动性溃疡[C5/6] 11.2%)和105名无症状参与者(无疾病[C0] 69.5%、毛细血管扩张[C1] 29.6%)。
- 多变量分析显示有症状CVD组与无症状组之间代谢谱存在差异,CVD组内不同CEAP临床分级之间也存在差异。
- 血清芳香族氨基酸与CEAP临床分级升高正相关(p<.001)。
- 尿甲酸、肌酐、甘氨酸、柠檬酸、琥珀酸、丙酮酸和2-羟基异丁酸与CEAP临床分级升高负相关(p<.001)。
- 这些代谢物涉及三羧酸循环、缺氧诱导因子通路和一碳代谢。
关键数值与推荐
- 疾病分期采用CEAP分类:毛细血管扩张[C1] 0.6%、静脉曲张[C2] 48.5%、肿胀[C3] 12.0%、皮肤改变[C4] 27.7%、愈合或活动性溃疡[C5/6] 11.2%。
- 无症状参与者中无疾病[C0] 69.5%、毛细血管扩张[C1] 29.6%。
- 血清芳香族氨基酸与CEAP临床分级升高正相关(p<.001)。
- 尿甲酸、肌酐、甘氨酸、柠檬酸、琥珀酸、丙酮酸和2-羟基异丁酸与CEAP临床分级升高负相关(p<.001)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Chronic venous disease (CVD) is a condition presenting a great burden to patients and society, with poorly characterised pathophysiology. Metabolic phenotyping can elucidate mechanisms of disease and identify candidate biomarkers. The aim of this study was to determine differences in the metabolic signature between symptomatic patients with CVD and asymptomatic volunteers using proton nuclear magnetic resonance spectroscopy (1H-NMR). METHODS: This was a prospective case control study of consecutive patients with symptomatic CVD and asymptomatic volunteers recruited from a single centre. Participants underwent clinical assessment, venous duplex ultrasound, and blood and urine sampling. Disease stage was defined according to the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification. 1H-NMR experiments were performed, with data analysed via multivariable statistical techniques. RESULTS: A total of 622 participants were recruited, including 517 symptomatic patients with CVD (telangiectasia [C1] 0.6%, varicose veins [C2] 48.5%, swelling [C3] 12.0%, skin changes [C4] 27.7%, healed or active ulceration [C5/6] 11.2%) and 105 asymptomatic participants (no disease [C0] 69.5%, telangiectasia [C1] 29.6%). Multivariable analysis revealed differences between the metabolic profile of the symptomatic CVD and asymptomatic groups, and between CEAP clinical classes in the CVD group. Serum aromatic amino acids positively correlated with increasing CEAP clinical class (p < .001). Urinary formate, creatinine, glycine, citrate, succinate, pyruvate, and 2-hydroxyisobutyrate negatively correlated with increasing CEAP clinical class (p < .001). These metabolites are involved in the tricarboxylic acid cycle, hypoxia inducible factor pathway, and one carbon metabolism. CONCLUSION: Untargeted biofluid analysis via 1H-NMR has detected metabolites associated with the presence and severity of CVD, highlighting biological pathways of relevance and providing candidate biomarkers to explore in future research.
引用
- Onida S, Lees HJ, Bergner R, et al. 1H Nuclear Magnetic Resonance Spectroscopy Reveals Changes in Metabolic Phenotype Associated with Disease Stage in Patients with Chronic Venous Disease. Eur J Vasc Endovasc Surg. 2024. PMID: 39303804. doi:10.1016/j.ejvs.2024.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。